| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 02/18/2009 | EP2023960A1 Conjugates of aziridinyl-epothilone analogs and pharmaceutical compositions comprising same |
| 02/18/2009 | EP2023959A1 Polyethylene glycol-interferon alpha conjugate |
| 02/18/2009 | EP2023958A1 Pharmaceutical product for intraoral delivery of nicotine comprising trometamol as buffering agent |
| 02/18/2009 | EP2023957A2 Oral liquid loratadine formulations and methods |
| 02/18/2009 | EP2023928A1 Coated pharmaceutical product for intraoral delivery of nicotine comprising trometamol as buffering agent |
| 02/18/2009 | EP2023813A2 Magnetic microparticles comprising organic substances |
| 02/18/2009 | EP2023810A2 Medical electrode containing a hydrophilic polymer |
| 02/18/2009 | EP2023748A2 Homogeneous dispersions containing citrus pulp and applications thereof |
| 02/18/2009 | EP1919945A4 Mutant of granulocyte-colony stimulating factor(g-csf) and chemically conjugated polypeptide thereof |
| 02/18/2009 | EP1904297A4 Compositions comprising elemental metals and uses therefor |
| 02/18/2009 | EP1562630A4 Injectible bioadhesive polymeric hydrogels as well as related methods of enzymatic preparation |
| 02/18/2009 | EP1534249A4 Chewable soft capsule |
| 02/18/2009 | EP1513493B1 Analgesics |
| 02/18/2009 | EP1496869B1 Coated particles with prolonged release and tablets containing same |
| 02/18/2009 | EP1135467B1 Psca: prostate stem cell antigen and uses thereof |
| 02/18/2009 | CN101370524A Lipopeptide compositions |
| 02/18/2009 | CN101370523A Method and composition |
| 02/18/2009 | CN101370493A Hydronol preparation |
| 02/18/2009 | CN101370482A Medicinal forms of phospholipid preparations and methods for their preparation |
| 02/18/2009 | CN101370481A Use of amphiphilic self-assembling proteins for formulating poorly water-soluble effect substances |
| 02/18/2009 | CN101370479A Nanoclusters for delivery of therapeutics |
| 02/18/2009 | CN101370478A Foam-forming composition |
| 02/18/2009 | CN101368187A Recombinant human FUS1 and human IL-12 dual-gene expression carrier, liposome complexes, preparation method and application thereof |
| 02/18/2009 | CN101367884A Cysteamine modified sulfhydryl hyaluronic acid couplet, preparation and application thereof |
| 02/18/2009 | CN101366974A Hydroxyphenyl cross-linked macromolecular network and applications thereof |
| 02/18/2009 | CN101366948A Sodium cholate coated liposoluble medicament metacortandracin intercalation hydrotalcite and preparation method thereof |
| 02/18/2009 | CN101366947A Method for inclusion of steroid medicament with hydrotalcite as carrier |
| 02/18/2009 | CN101366946A Starch based segmented intestine targeting specific adhesion material, preparation and application thereof |
| 02/18/2009 | CN101366939A Compound traditional Chinese medicine Xintongling nano-microcapsule and preparation thereof |
| 02/18/2009 | CN101366814A Novel medicament for treating systematic lupus erythematosus |
| 02/18/2009 | CN101366722A Hydrotalcite doxifluridine slow release formulation and preparation method thereof |
| 02/18/2009 | CN101366715A Rapamycin composition and preparation thereof |
| 02/18/2009 | CN101366701A N, N-dimethyl collagen sugar-2, 6-diisopropyl benzene ester salt injection |
| 02/18/2009 | CN101366700A Hydrophilic medicament dual-microsphere formulation and preparation method thereof |
| 02/18/2009 | CN101366699A Novel formulation of dehydrated lipid vesicles for controlled release of active pharmaceutical ingredient via inhalation |
| 02/18/2009 | CN101366698A Biogastrone acid prosome liposome with long circulation function and preparation method thereof |
| 02/18/2009 | CN101366696A Medicament composition for water-soluble injection of paclitaxel, preparation method and uses thereof |
| 02/18/2009 | CN101366694A Tribiofosfor injection and preparation method thereof |
| 02/18/2009 | CN101366693A Drug delivery system |
| 02/18/2009 | CN100462103C Cholesterol phosphononucleoside analogue |
| 02/18/2009 | CN100462083C Method for relieving bitter taste in compound Chinese medicine |
| 02/18/2009 | CN100462079C Externally applied sulfamylonum formulation and its preparation method |
| 02/18/2009 | CN100462075C Nanometer miconazole nitrate emulsion medicine and its preparation process |
| 02/18/2009 | CN100462074C Chewing tablet with vision fatigue relieving function |
| 02/18/2009 | CN100462071C Sustained release Brufen having magnetic super-molecular inserting layer structure and its preparation method |
| 02/18/2009 | CN100462067C Preparation method of sodium iron chlorophyllin-ethyl cellulose microcapsule |
| 02/17/2009 | US7491836 Polyoxyalkylene glycols or monoalkylated polyoxyalkylene glycols esterified with O-acylated, O-alkylated or O-alkenylated hydroxy fatty acids; high bioavailability |
| 02/17/2009 | US7491805 Biological conjugates used for drug delivery; side effect reduction |
| 02/17/2009 | US7491801 Identification and development of specific monoclonal antibodies to squamous cell carcinoma |
| 02/17/2009 | US7491796 Retro-inversion peptides that target GIT receptors and related methods |
| 02/17/2009 | US7491708 Modified pectin |
| 02/17/2009 | US7491692 admixing a supplement selected from the therapeutically active agents for facilitating axon growth and a flowable carrier component capable of forming a matrix in vivo at a nerve lesion site and the active agent is releasable from the matrix |
| 02/17/2009 | US7491690 Self-assembly and mineralization of peptide-amphiphile nanofibers |
| 02/17/2009 | US7491537 Nucleic acid formulations for gene delivery and methods of use |
| 02/17/2009 | US7491516 Dual specificity antibodies and methods of making and using |
| 02/17/2009 | US7491411 dialysis or replacement fluid separated into two or more component solutions intended for admixture to use, provides the final dialysis or replacement fluid; aqueous NaHCO3 in one compartment, dissolved CO2 in separate compartment containing HCl or lactic or CH3COOH, NaCl, MgCl2, KCl, CaCl2, glucose |
| 02/17/2009 | US7491406 Fast dissolving orally consumable films |
| 02/17/2009 | US7491403 containing a sequestration agent including proteins, lipids and carbohydrates, particularly albumin; treating neuromuscular diseases and pain |
| 02/17/2009 | US7491383 Solubilizer, and a anionic polymer or fatty acid in complex with a therapeutic |
| 02/17/2009 | US7491047 Delivery of antihistamines through an inhalation route |
| 02/17/2009 | CA2494825C Injectable pharmaceutical suspension in a two-chamber vial |
| 02/17/2009 | CA2381404C Ointment applicator and ointment patch using the same |
| 02/17/2009 | CA2371925C Antibacterial compositions |
| 02/17/2009 | CA2356087C Methods and compositions for treatment of cell proliferative disorders |
| 02/17/2009 | CA2352362C Nanoparticles with polymer shells |
| 02/17/2009 | CA2347856C Dry powder for inhalation |
| 02/17/2009 | CA2334267C Use of peg-ifn-alpha and ribavirin for the treatment of chronic hepatitis c |
| 02/17/2009 | CA2325983C Drug delivery of proteins from polymeric blends |
| 02/17/2009 | CA2299464C Controlled release pharmaceutical compositions containing tiagabine |
| 02/17/2009 | CA2282812C Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereof |
| 02/17/2009 | CA2233166C Hormone immunomodulated induction of mucosal immune responses |
| 02/17/2009 | CA2231404C Novel cyclosporine preparation forms for oral administration of simple composition and high bio-availability, and process for producing them |
| 02/17/2009 | CA2164984C Recombinant disulfide-stabilized polypeptide fragments having binding specificity |
| 02/17/2009 | CA2138928C Immunoconjugates |
| 02/13/2009 | CA2637524A1 Drug delivery system |
| 02/12/2009 | WO2009021136A1 Chlorotoxins as drug carriers |
| 02/12/2009 | WO2009021017A2 Nucleic acid-lipopolymer compositions |
| 02/12/2009 | WO2009020987A2 Process for preparation of swellable and degradable microspheres |
| 02/12/2009 | WO2009020645A2 Matriptase protein and uses thereof |
| 02/12/2009 | WO2009020104A1 Gel-like composition for external application comprising adenine compound |
| 02/12/2009 | WO2009020094A1 Antibody modified with hydrophobic molecule |
| 02/12/2009 | WO2009020093A1 Immunoliposome inducing apoptosis into cell expressing death domain-containing receptor |
| 02/12/2009 | WO2009020058A1 Drug delivery system toward demyelinating lesion and biochemical marker of demyelinating lesion |
| 02/12/2009 | WO2009019891A1 Inverted vesicle |
| 02/12/2009 | WO2009019840A1 Propylene glycol hyaluronate ester and external preparation for skin using the same |
| 02/12/2009 | WO2009019835A1 Crude drug extract-blended liquid medicine |
| 02/12/2009 | WO2009019314A1 Transferrin variants and conjugates |
| 02/12/2009 | WO2008152669A3 Colloidal vectors with polyaminoacid structure for oral release of peptides and proteins and method for their production |
| 02/12/2009 | WO2008145338A3 Monoclonal antibodies against claudin-18 for treatment of cancer |
| 02/12/2009 | WO2008142231A3 Novel composition based on cholest-4-ene-3-one oxime |
| 02/12/2009 | WO2008100481A3 Lung cancer-targeted peptides and applications thereof |
| 02/12/2009 | WO2008089426A3 Methods and compositions for the delivery of a therapeutic agent |
| 02/12/2009 | WO2008086330A3 Formulations of deacetylase inhibitors |
| 02/12/2009 | WO2008064163A3 Polymer coated drug-ion exchange resins and methods |
| 02/12/2009 | WO2008035020A3 Galenic form for the trans-mucosal delivery of active ingredients |
| 02/12/2009 | WO2008006187A3 Protein complexes for prevention and treatment of diseases with angiogenesis disorders |
| 02/12/2009 | US20090043077 Conjugation of streptococcal capsular saccharides |
| 02/12/2009 | US20090042997 For lowering surface tension; improve surfactant or surface treating agent performance and to increase the fluorine efficiency; lower proportion of the expensive fluorine component is required to achieve desired levels of performance |
| 02/12/2009 | US20090042989 Nsaid formulations, based on highly adaptable aggregates, for improved transport through barriers and topical drug delivery |
| 02/12/2009 | US20090042952 Sustained Release Composition for Oral Administration of Niacin |